During the past decade, Cancer Center of Santa Barbara conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 16 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 9 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cancer Center of Santa Barbara" #1 sponsor was "Gilead Sciences" with 3 trials, followed by "National Cancer Institute (NCI)" with 3 trials sponsored, "Pfizer" with 3 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "NRG Oncology" with 2 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Center of Santa Barbara" #1 collaborator was "National Cancer Institute (NCI)" with 8 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "American College of Surgeons" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Cancer Center of Santa Barbara" are "Breast Cancer" (3 trials), "Breast Neoplasms" (2 trials), "Cancer" (2 trials), "Chronic Lymphocytic Leukemia" (2 trials) and "Esophageal Cancer" (2 trials). Many other conditions were trialed in "Cancer Center of Santa Barbara" in a lesser frequency.

Most popular intervention types in "Cancer Center of Santa Barbara" are "Drug" (28 trials), "Other" (9 trials), "Biological" (5 trials), "Radiation" (4 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (5 trials), "Carboplatin" (4 trials), "Laboratory Biomarker Analysis" (4 trials), "Placebo" (4 trials) and "Idelalisib" (3 trials). Other intervention names were less common.

The vast majority of trials in "Cancer Center of Santa Barbara" are 22 trials for "All" genders, 10 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Cancer Center of Santa Barbara". undefined are not yet recruiting, 9 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Cancer Center of Santa Barbara, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Cancer Center of Santa Barbara, 4 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Cancer Center of Santa Barbara has several departments that took part in Clinical trials: "Santa Barbara Hematology Oncology - Solvang" - 5 trials